Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,674 | 85 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $369.79 | 15 | $0 (2023) |
| PFIZER INC. | $158.15 | 12 | $0 (2019) |
| Novartis Pharmaceuticals Corporation | $158.10 | 6 | $0 (2020) |
| Lilly USA, LLC | $147.54 | 3 | $0 (2019) |
| Life Molecular Imaging Ltd | $135.00 | 1 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $100.48 | 7 | $0 (2018) |
| AstraZeneca Pharmaceuticals LP | $94.84 | 8 | $0 (2019) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $55.43 | 4 | $0 (2018) |
| Astellas Pharma US Inc | $54.86 | 3 | $0 (2019) |
| Radius Health, Inc. | $53.20 | 2 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $159.78 | 2 | Life Molecular Imaging Ltd ($135.00) |
| 2023 | $143.08 | 2 | GlaxoSmithKline, LLC. ($143.08) |
| 2020 | $43.59 | 3 | Novartis Pharmaceuticals Corporation ($16.00) |
| 2019 | $301.58 | 19 | PFIZER INC. ($52.49) |
| 2018 | $459.33 | 30 | GlaxoSmithKline, LLC. ($140.94) |
| 2017 | $567.06 | 29 | Lilly USA, LLC ($133.95) |
All Payment Transactions
85 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 04/24/2024 | Life Molecular Imaging Ltd | NEURACEQ (Drug) | Food and Beverage | Cash or cash equivalent | $135.00 | General |
| Category: Diagnostic Tracer | ||||||
| 04/13/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $24.78 | General |
| 11/07/2023 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $124.74 | General |
| Category: RESPIRATORY | ||||||
| 09/14/2023 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY | Food and Beverage | In-kind items and services | $18.34 | General |
| Category: VACCINES | ||||||
| 02/18/2020 | Novartis Pharmaceuticals Corporation | AIMOVIG (Biological) | Food and Beverage | In-kind items and services | $16.00 | General |
| Category: NEUROSCIENCE | ||||||
| 01/21/2020 | Amgen Inc. | Aimovig (Biological), Repatha | Food and Beverage | In-kind items and services | $12.72 | General |
| Category: Neuroscience | ||||||
| 01/13/2020 | Teva Pharmaceuticals USA, Inc. | AJOVY (Biological) | Food and Beverage | In-kind items and services | $14.87 | General |
| Category: Central Nervous System | ||||||
| 12/17/2019 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $12.41 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/03/2019 | SI-BONE, Inc. | iFuse Implant (Device) | Food and Beverage | In-kind items and services | $16.73 | General |
| Category: sacroiliac joint dysfunction | ||||||
| 10/29/2019 | Regeneron Healthcare Solutions, Inc. | PRALUENT (Biological) | Food and Beverage | In-kind items and services | $14.34 | General |
| Category: CARDIOVASCULAR AND METABOLISM | ||||||
| 08/27/2019 | PFIZER INC. | CHANTIX (Drug), EUCRISA, COLOGUARD | Food and Beverage | In-kind items and services | $15.06 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 07/30/2019 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), ANORO | Food and Beverage | In-kind items and services | $13.91 | General |
| Category: RESPIRATORY | ||||||
| 07/09/2019 | Takeda Pharmaceuticals U.S.A., Inc. | Trintellix (Drug) | Food and Beverage | In-kind items and services | $39.72 | General |
| Category: Central Nervous System (CNS) | ||||||
| 06/18/2019 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $16.38 | General |
| Category: Hypertriglyceridemia | ||||||
| 06/04/2019 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $14.52 | General |
| Category: CARDIOVASCULAR | ||||||
| 05/17/2019 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $10.90 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 05/14/2019 | Amgen Inc. | Aimovig (Biological) | Food and Beverage | In-kind items and services | $16.85 | General |
| Category: Neuroscience | ||||||
| 04/15/2019 | Tris Pharma Inc | Quillivant XR (Drug) | Food and Beverage | In-kind items and services | $11.33 | General |
| Category: ADHD | ||||||
| 04/02/2019 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $20.26 | General |
| Category: UROLOGY | ||||||
| 03/19/2019 | PFIZER INC. | LYRICA (Drug), EUCRISA, COLOGUARD | Food and Beverage | In-kind items and services | $12.16 | General |
| Category: NEUROSCIENCE;PAIN | ||||||
| 03/06/2019 | PFIZER INC. | LYRICA (Drug), EUCRISA, COLOGUARD | Food and Beverage | In-kind items and services | $14.37 | General |
| Category: NEUROSCIENCE;PAIN | ||||||
| 02/22/2019 | Amgen Inc. | Prolia (Biological), Repatha | Food and Beverage | In-kind items and services | $13.55 | General |
| Category: Bone Health | ||||||
| 02/12/2019 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $11.25 | General |
| Category: CARDIOVASCULAR | ||||||
| 02/05/2019 | Novo Nordisk Inc | Tresiba (Drug) | Food and Beverage | In-kind items and services | $22.14 | General |
| Category: Diabetes | ||||||
| 01/22/2019 | Lilly USA, LLC | EMGALITY (Drug) | Food and Beverage | In-kind items and services | $13.59 | General |
| Category: Neuroscience | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 122 | 228 | $64,418 | $17,607 |
| 2022 | 5 | 86 | 214 | $79,456 | $17,252 |
| 2021 | 4 | 102 | 137 | $53,138 | $12,907 |
| 2020 | 6 | 257 | 464 | $107,553 | $27,357 |
All Medicare Procedures & Services
23 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 36 | 126 | $35,312 | $9,031 | 25.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 25 | 25 | $5,000 | $3,063 | 61.3% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 14 | 14 | $11,347 | $2,236 | 19.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 14 | 24 | $9,034 | $2,184 | 24.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 11 | 17 | $3,285 | $714.48 | 21.7% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 22 | 22 | $440.00 | $379.06 | 86.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 30 | 132 | $36,993 | $9,467 | 25.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 15 | 30 | $11,293 | $3,510 | 31.1% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 18 | 21 | $17,021 | $3,106 | 18.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 11 | 17 | $3,285 | $1,023 | 31.1% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 12 | 14 | $10,864 | $146.58 | 1.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 35 | 59 | $14,288 | $4,290 | 30.0% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 21 | 32 | $12,045 | $4,033 | 33.5% |
| 45385 | Removal of polyps or growths in large bowel using an endoscope (colonoscopy) using a mechanical snare | Facility | 2021 | 17 | 17 | $13,830 | $3,176 | 23.0% |
| 45380 | Biopsy of the large bowel using an endoscope (colonoscopy) | Facility | 2021 | 13 | 13 | $10,264 | $1,328 | 12.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 16 | 16 | $2,710 | $79.70 | 2.9% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 146 | 338 | $54,756 | $16,002 | 29.2% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope | Facility | 2020 | 28 | 28 | $24,136 | $5,757 | 23.9% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2020 | 12 | 12 | $7,680 | $2,239 | 29.2% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 29 | 34 | $3,740 | $1,049 | 28.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 14 | 15 | $2,430 | $898.68 | 37.0% |
| 45380 | Biopsy of large bowel using an endoscope | Facility | 2020 | 15 | 15 | $12,300 | $783.22 | 6.4% |
| 20610 | Aspiration and/or injection of large joint or joint capsule | Facility | 2020 | 13 | 22 | $2,511 | $627.39 | 25.0% |
About Dr. Todd Rexford, MD
Dr. Todd Rexford, MD is a Family Medicine healthcare provider based in Norton Shores, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/10/2005. The National Provider Identifier (NPI) number assigned to this provider is 1740284330.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Todd Rexford, MD has received a total of $1,674 in payments from pharmaceutical and medical device companies, with $159.78 received in 2024. These payments were reported across 85 transactions from 25 companies. The most common payment nature is "Food and Beverage" ($1,674).
As a Medicare-enrolled provider, Rexford has provided services to 567 Medicare beneficiaries, totaling 1,043 services with total Medicare billing of $75,123. Data is available for 4 years (2020–2023), covering 23 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Norton Shores, MI
- Active Since 06/10/2005
- Last Updated 03/12/2021
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1740284330
Products in Payments
- ENTRESTO (Drug) $142.10
- NEURACEQ (Drug) $135.00
- TRULICITY (Drug) $133.95
- AREXVY (Drug) $124.74
- CHANTIX (Drug) $96.00
- SHINGRIX (Biological) $93.69
- XARELTO (Drug) $69.36
- FARXIGA (Drug) $56.74
- Tymlos (Biological) $53.20
- LYRICA (Drug) $50.92
- Trintellix (Drug) $50.88
- ANORO (Drug) $38.18
- SYMBICORT (Drug) $38.10
- Myrbetriq (Drug) $34.60
- INVOKANA (Drug) $31.12
- Aimovig (Biological) $29.57
- VYVANSE (Drug) $28.12
- JARDIANCE (Drug) $27.70
- ELIQUIS (Drug) $25.57
- BEXSERO (Biological) $25.38
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Norton Shores
Dr. Scott Addison, Md, MD
Family Medicine — Payments: $3,599
Dr. James Twesten-Otoole, Md, MD
Family Medicine — Payments: $2,668
Gabriel Dunn, M.d, M.D
Family Medicine — Payments: $2,557
Michael Banka, Md, MD
Family Medicine — Payments: $1,705
Dr. David Booth, Md, MD
Family Medicine — Payments: $1,684
Alex Wagner, Do, DO
Family Medicine — Payments: $1,549